Aakaar Medical Technologies IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jun 20 to Jun 24 2025
Price Band
₹72
Current GMP
₹75(4.77%)
Subscription
2.28 times
IPO Details
| IPO Date | June 20, 2025 to June 24, 2025 |
| Listing Date | June 27, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹72 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 37,50,400 shares (aggregating up to ₹27.00 Cr) |
| Reserved for Market Maker | 1,88,800 shares (aggregating up to ₹1.36 Cr)Alacrity Securities Ltd. |
| Net Offered to Public | 35,61,600 shares (aggregating up to ₹25.64 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,04,22,416 shares |
| Share Holding Post Issue | 1,41,72,816 shares |
IPO Date
June 20, 2025 to June 24, 2025
Listing Date
June 27, 2025
Face Value
₹10 per share
Issue Price
₹72 per share
Lot Size
1,600 Shares
Sale Type
Fresh Capital
Total Issue Size
37,50,400 shares (aggregating up to ₹27.00 Cr)
Reserved for Market Maker
1,88,800 shares (aggregating up to ₹1.36 Cr)Alacrity Securities Ltd.
Net Offered to Public
35,61,600 shares (aggregating up to ₹25.64 Cr)
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Share Holding Pre Issue
1,04,22,416 shares
Share Holding Post Issue
1,41,72,816 shares
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| Qualified Institutions | 3.51 |
| Non-Institutional Buyers*** | 1.48 |
| Retail Investors | 1.93 |
| Total ** | 2.28 |
Anchor Investors
1
Market Maker
1
Qualified Institutions
3.51
Non-Institutional Buyers***
1.48
Retail Investors
1.93
Total **
2.28
Day Wise Sub
| Day | QIB | NII* | Retail | Total |
|---|---|---|---|---|
| Day 1 Jun 20, 2025 | 0.33 | 0.59 | 0.31 | 0.37 |
| Day 2 Jun 23, 2025 | 0.33 | 0.66 | 0.89 | 0.68 |
| Day 3 Jun 24, 2025 | 3.51 | 1.48 | 1.93 | 2.28 |
DayDay 1
Jun 20, 2025
QIB0.33
NII*0.59
Retail0.31
Total0.37
DayDay 2
Jun 23, 2025
QIB0.33
NII*0.66
Retail0.89
Total0.68
DayDay 3
Jun 24, 2025
QIB3.51
NII*1.48
Retail1.93
Total2.28
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 27-06-2025 | 72.00 | 0(0.00%) | 72 |
| 26-06-2025 | 72.00 | 0(0.00%) | 72 |
| 25-06-2025 | 72.00 | 0(0.00%) | 72 |
| 24-06-2025 | 72.00 | 0(0.00%) | 72 |
| 23-06-2025 | 72.00 | 0(0.00%) | 72 |
| 22-06-2025 | 72.00 | 0(0.00%) | 72 |
| 21-06-2025 | 72.00 | 0(0.00%) | 72 |
| 20-06-2025 | 72.00 | 0(0.00%) | 72 |
| 19-06-2025 | 72.00 | 0(0.00%) | 72 |
| 18-06-2025 | 72.00 | 0(0.00%) | 72 |
| 17-06-2025 | 72.00 | 0(0.00%) | 72 |
Date27-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date26-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date25-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date24-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date23-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date22-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date21-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date20-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date19-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date18-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
Date17-06-2025
Price72.00
GMP0(0.00%)
Estimate List Price72
IPO Important Dates
| IPO Open Date | Fri, Jun 20, 2025 |
| IPO Close Date | Tue, Jun 24, 2025 |
| Tentative Allotment | Wed, Jun 25, 2025 |
| Initiation of Refunds | Thu, Jun 26, 2025 |
| Credit of Shares to Demat | Thu, Jun 26, 2025 |
| Tentative Listing Date | Fri, Jun 27, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 24, 2025 |
IPO Open Date
Fri, Jun 20, 2025
IPO Close Date
Tue, Jun 24, 2025
Tentative Allotment
Wed, Jun 25, 2025
Initiation of Refunds
Thu, Jun 26, 2025
Credit of Shares to Demat
Thu, Jun 26, 2025
Tentative Listing Date
Fri, Jun 27, 2025
Cut-off time for UPI mandate confirmation
5 PM on June 24, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹1,15,200 |
| Retail (Max) | 1 | 1600 | ₹1,15,200 |
| HNI (Min) | 2 | 3,200 | ₹2,30,400 |
ApplicationRetail (Min)
Lots1
Shares1600
Amount₹1,15,200
ApplicationRetail (Max)
Lots1
Shares1600
Amount₹1,15,200
ApplicationHNI (Min)
Lots2
Shares3,200
Amount₹2,30,400
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 51.85 | 34.01 | 23.23 |
| Revenue | 61.76 | 46.27 | 32.88 |
| Profit After Tax | 6.04 | 2.87 | 2.15 |
| EBITDA | 9.74 | 5.00 | 3.53 |
| Net Worth | 23.20 | 12.53 | 9.66 |
| Reserves and Surplus | 12.78 | 11.84 | 8.96 |
| Total Borrowing | 22.74 | 15.06 | 5.87 |
Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 202551.85
31 Mar 202434.01
31 Mar 202323.23
Period EndedRevenue
31 Mar 202561.76
31 Mar 202446.27
31 Mar 202332.88
Period EndedProfit After Tax
31 Mar 20256.04
31 Mar 20242.87
31 Mar 20232.15
Period EndedEBITDA
31 Mar 20259.74
31 Mar 20245.00
31 Mar 20233.53
Period EndedNet Worth
31 Mar 202523.20
31 Mar 202412.53
31 Mar 20239.66
Period EndedReserves and Surplus
31 Mar 202512.78
31 Mar 202411.84
31 Mar 20238.96
Period EndedTotal Borrowing
31 Mar 202522.74
31 Mar 202415.06
31 Mar 20235.87
IPO Reservation
| Market Maker Shares Offered | 1,88,800 (4.79%) |
| QIB Shares Offered | 17,79,200 (45.15%) |
| − Anchor Investor Shares Offered | 10,67,200 (27.08%) |
| − QIB (Ex. Anchor) Shares Offered | 7,12,000 (18.07%) |
| NII (HNI) Shares Offered | 5,36,000 (13.60%) |
| Retail Shares Offered | 12,48,000 (31.67%) |
| Total Shares Offered | 39,40,800 (100.00%) |
Market Maker Shares Offered
1,88,800 (4.79%)
QIB Shares Offered
17,79,200 (45.15%)
− Anchor Investor Shares Offered
10,67,200 (27.08%)
− QIB (Ex. Anchor) Shares Offered
7,12,000 (18.07%)
NII (HNI) Shares Offered
5,36,000 (13.60%)
Retail Shares Offered
12,48,000 (31.67%)
Total Shares Offered
39,40,800 (100.00%)
Information about company
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.
The company deals in speciality products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, Cosmetologists.
The company's product portfolio encompasses both own brands, which consist of domestically manufactured products and internationally produced devices, and imported brands sourced from countries such as South Korea, Spain, Italy, and Austria.
The company supplies products and devices mainly to dermatologists, plastic surgeons, and aesthetic physicians, who sell them to end consumers and use some consumables in treatments.
The company's product range includes the following:-
Homecare and professional skin care
Injectable and contouring, Homecare for skin, Professional Hair Care
Injectable and contouring, Homecare for skin
Professional Skincare products
Hair Growth Serum & Tablets
Hair Serum, Anti hair loss solution, Tablet
Medifacial Kit
Device for urinary incontinence
Tattoo removal, pigmentation and skin rejuvenation devices
Laser Hair Reduction devices
Hair Transplant Device
The company has branches across India with a team of 90 trained sales and service engineers, serving thousands of satisfied customers.
The company sells its products to the states of Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Competitive Strength
Experienced Management & Leadership Team
Diversified Customer Base
Diversified Product Base
Pan India reach through our Consignment Sales partner.
Objectives of IPO
The Company Aakaar Medical Technologies IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (Rs. in crores)
1
Funding working capital requirements of the Company
20.35
2
General corporate purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App